EXCHANGE AGREEMENTExchange Agreement • March 16th, 2010 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • New Jersey
This Exchange Agreement (this “Agreement”) is dated as of [ ] (the “Effective Date”), by and among Radient Pharmaceuticals Corporation., a Delaware corporation (the “Company”) with an address at 2492 Walnut Ave. Suite 100 Tustin, CA 92780-6953 and each of the Note Holders of the 12% Senior Note issued in December 2008 and January 30, 2009 (the “Series 1 Note Holders”) and each of the Note Holders of the 12% Series 2 Senior Promissory Note issued in May and June 2009 (the “Series 2 Note Holders, together with the Series 1 Note Holders, the “Note Note Holders”) whose names are set forth on Exhibit A and Exhibit B hereto.
WAIVER OF DEFAULTWaiver of Default • March 16th, 2010 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • Illinois
This Waiver of Default (this “Waiver”) is entered into as of February 16, 2010, by and between St. George Investments, LLC, an Illinois limited liability company (“Lender”), and Radiant Pharmaceuticals, Inc., a Delaware corporation (formerly AMDL, Inc.) (“Borrower”).
